• Home
  • Products & Services
    • VBS Pharmaceuticals
      • CAR Peptide Technology
      • CAR Peptide Applications
        • Co-administered Therapeutics
        • Pulmonary Hypertension
        • Sepsis
        • Gene Therapy
    • VBS Interventional
      • Interventional Technology
        • Endoarterial Biopsy Catheter
        • Endoarterial Biopsy Procedure
        • Endoarterial Biopsy Sequence
        • Endoarterial Biopsy Sample
        • Single Use Components
        • Endoarterial Biopsy Kit
      • Interventional Applications
        • Pulmonary Arterial Hypertension
        • Peripheral Vascular Disease
        • Lung Transplant Rejection
        • Vasculitis/Collagen Vascular Disease
        • Coronary Artery Disease
        • Critical Care Applications — Acute Lung Injury & Acute Respiratory Distress Syndrome
        • Lung Cancer
    • VBS Molecular Diagnostics
      • Molecular Diagnostics Technology
  • Product Pipeline
  • COVID-19
  • News
  • About VBS
    • VBS Team
    • VBS Board of Directors
  • VBS Scientific Articles
  • Investment
  • Contact

Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension” Selected by Faculty of 1000

Jun 24, 2011
by admin
Comments are off
Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension” Selected by Faculty of 1000 Goleta, Calif., June 24, 2011 – A recently published paper from Vascular BioSciences (VBS) in collaboration with Sanford-Burnham Medical Research Institute and the University of
Read More

VBS Pharmaceuticals announces publication of “Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension”

Jun 10, 2011
by admin
Comments are off
VBS Pharmaceuticals announces publication of “Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension” Goleta, Calif., June 10, 2011 – VBS Pharmaceuticals, in collaboration with the Sanford-Burnham Medical Research Institute, and the University of South Alabama,
Read More

David Mann, CEO of Vascular BioSciences, Presents Opening Remarks at the Southern California Undergraduate Research Conference in Chemistry and Biochemistry (SCURC)

Apr 24, 2011
by admin
Comments are off
David Mann, CEO of Vascular BioSciences, Presents Opening Remarks at the Southern California Undergraduate Research Conference in Chemistry and Biochemistry (SCURC) Santa Barbara, Calif., April 24, 2011 – Opening speaker David Mann presented the following remarks at the SCURC at the U
Read More

Vascular BioSciences to Sponsor 2011 Southern California Undergraduate Research Conference in Chemistry and Biochemistry

Apr 23, 2011
by admin
Comments are off
Vascular BioSciences to Sponsor 2011 Southern California Undergraduate Research Conference in Chemistry and Biochemistry Santa Barbara, Calif., April 23, 2011 – Vascular BioSciences will be a major sponsor of the 2011 Southern California Undergraduate Research Conference in Chemistry
Read More

Vascular BioSciences, In Collaboration with the University of South Alabama, Awarded Exploration/Development R21 Grant from the National Heart Lung Blood Institute of the National Institutes of Health for Cell-targeted Drug Delivery for the Treatment of Pulmonary Arterial Hypertension (PAH)

Dec 24, 2010
by admin
Comments are off
Vascular BioSciences, In Collaboration with the University of South Alabama, Awarded Exploration/Development R21 Grant from the National Heart Lung Blood Institute of the National Institutes of Health for Cell-targeted Drug Delivery for the Treatment of Pulmonary Arterial Hypertension
Read More

Vascular BioSciences Awarded Qualifying Therapeutic Discovery Project Grant to Develop CAR Peptide as a Therapeutic Adjuvant

Nov 09, 2010
by admin
Comments are off
Vascular BioSciences Awarded Qualifying Therapeutic Discovery Project Grant to Develop CAR Peptide as a Therapeutic Adjuvant San Diego, CA, November 9, 2010 – Vascular BioSciences was awarded a grant in the amount of $181,876 from the U.S. Government’s Qualifying Therapeutic Discovery
Read More

Vascular BioSciences Opens New Office and Pilot Catheter Manufacturing Facility in Goleta, California

Jan 08, 2010
by admin
Comments are off
Vascular BioSciences Opens New Office and Pilot Catheter Manufacturing Facility in Goleta, California Goleta, Calif., January 8, 2010 – Vascular BioSciences announced today that it has opened a new office and pilot catheter manufacturing facility in Goleta, California. The new Goleta
Read More

Vascular BioSciences CEO David Mann Awarded New U.S. and European Patents for Endorterial Biopsy Catheterization Equipment Kit Invention

Feb 18, 2009
by admin
Comments are off
Vascular BioSciences CEO David Mann Awarded New U.S. and European Patents for Endorterial Biopsy Catheterization Equipment Kit Invention San Diego, CA, February 18, 2009 – Vascular BioSciences announced today that it was awarded US Patent No. 7,491,176 titled “A Kit for Obtaining an E
Read More

Abraham Rothman, M.D. to Present “Pulmonary Endoarterial Biopsy” at the Society for Cardiovascular Angiography and Interventions at the American College of Cardiology Annual Innovation in Intervention Meeting in Chicago, Illinois

Mar 28, 2008
by admin
Comments are off
Abraham Rothman, M.D. to Present “Pulmonary Endoarterial Biopsy” at the Society for Cardiovascular Angiography and Interventions at the American College of Cardiology Annual Innovation in Intervention Meeting in Chicago, Illinois Chicago, Illinois, March 28, 2008 – Vascular BioScience
Read More

Vascular BioSciences Awarded STTR Matching Grant from the State of North Carolina

Mar 26, 2008
by admin
Comments are off
Vascular BioSciences Awarded STTR Matching Grant from the State of North Carolina Durham, North Carolina, March 26, 2008 – Vascular BioSciences announced today it has been awarded a $100,000 STTR matching grant under the One North Carolina SBIR/STTR Matching Funds Program. The One Nor
Read More
1234
  • Home
  • Products & Services
  • Product Pipeline
  • News
  • About VBS
  • VBS Scientific Articles
  • Investment
  • Contact Info
  • Privacy Policy